Douglas Lane & Associates, LLC Eli Lilly & CO Transaction History

Douglas Lane & Associates, LLC

$6.79 Billion
Q1 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 2,945 shares of LLY stock, worth $2.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,945

Previous 3,267 9.86%

Holding current value

$2.67 Million

Previous $1.9 Million 20.33%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $190,688 - $255,114	-322 Reduced 9.86%	2,945 $2.29 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $84,555 - $99,679	-161 Reduced 4.7%	3,267 $1.9 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $8,259 - $11,386	19 Added 0.56%	3,428 $1.84 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $701 - $937	-2 Reduced 0.06%	3,409 $1.6 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $53,117 - $62,384	171 Added 5.28%	3,411 $1.17 Million

Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $1,607 - $1,873	5 Added 0.15%	3,240 $1.19 Million
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $25,200 - $28,718	-85 Reduced 2.56%	3,235 $1.05 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $34,562 - $40,581	-124 Reduced 3.6%	3,320 $1.08 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $96,926 - $120,455	-413 Reduced 10.71%	3,444 $986,000
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $3,372 - $4,185	15 Added 0.39%	3,857 $1.07 Million
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $87,088 - $107,175	-393 Reduced 9.28%	3,842 $888,000
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $1,444 - $1,868	8 Added 0.19%	4,235 $972,000
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $73,615 - $95,298	-448 Reduced 9.58%	4,227 $790,000
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $9,001 - $11,911	-69 Reduced 1.45%	4,675 $789,000
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $17,546 - $20,295	-120 Reduced 2.47%	4,744 $702,000
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $55,522 - $66,821	407 Added 9.13%	4,864 $799,000
Q1 2020 Apr 20, 2020	SELL	$119.05 - $147.35 $144,645 - $179,030	-1,215 Reduced 21.42%	4,457 $618,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $21,384 - $26,486	200 Added 3.65%	5,672 $745,000
Q3 2019 Oct 16, 2019	BUY	$106.79 - $116.16 $320 - $348	3 Added 0.05%	5,472 $612,000
Q2 2019 Jul 08, 2019	SELL	$110.79 - $129.32 $8,863 - $10,345	-80 Reduced 1.44%	5,469 $606,000
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $16,696 - $19,653	-150 Reduced 2.63%	5,549 $720,000
Q4 2018 Jan 17, 2019	BUY	$105.9 - $118.64 $85,779 - $96,098	810 Added 16.57%	5,699 $659,000
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $160,644 - $200,777	-1,871 Reduced 27.68%	4,889 $525,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $511,732 - $587,308	6,760 New	6,760 $577,000
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $194,607 - $208,738	-2,375 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$77.07 - $85.54 $183,041 - $203,157	2,375	2,375 $203,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Eli Lilly & CO Transaction History